Research library
Prepared by Pillar Research
CJC-1295 with DAC
Sources and editorial policyA long-acting GHRH analogue used to study pituitary signalling and duration-of-exposure questions.
Evidence limits
Published findings describe specific research and clinical-study contexts. They do not establish a product-specific use, safety profile, or administration protocol.
Sources
For current strength, AUD price, purity, batch COA and Australian dispatch, see CJC-1295 with DAC 5mg (CJC-1295 DAC Peptide) product specifications.